Characterizing Low-Risk Breast and Gynecological Cancer Patients for Transition into an Oncology/Primary Care Coordinated Care Model: Findings from a Survey of Diverse Survivors in a Rural U.S. State

We conducted a survey to characterize the key attributes of racial/ethnic and geographically diverse low-risk breast and gynecologic cancer patients. We collected data regarding patients' access to primary care (PC); compliance with screening recommendations; treatment for comorbidities; logist...

Full description

Saved in:
Bibliographic Details
Published in:Cancers 2021-09, Vol.13 (17), p.4428
Main Authors: Kano, Miria, Chen, Lu, Boyce, Tawny, Gomez, Ricardo, Gundelach, Amy C, Jaffe, Shoshana Adler, Sussman, Andrew L, Dayao, Zoneddy R, Lobo, Jolene, Pestak, Claire R, Rutledge, Teresa L
Format: Article
Language:English
Subjects:
Breast cancer
Cancer therapies
Communication
Comorbidity
Demographics
Diabetes mellitus
Ethnicity
Family income
Gynecology
Health care access
Health services utilization
Hispanic Americans
Hypothesis testing
Medical screening
Oncology
Patients
Prevention
Primary care
Rural areas
Surveillance
Survival
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We conducted a survey to characterize the key attributes of racial/ethnic and geographically diverse low-risk breast and gynecologic cancer patients. We collected data regarding patients' access to primary care (PC); compliance with screening recommendations; treatment for comorbidities; logistical barriers to clinic visits; and receipt of survivorship care documentation (SCD). Survey findings informed the development of an oncology/Primary Care Provider (PCP) care coordination intervention to improve care. We distributed a cross-sectional survey among a convenience sample of 150 cancer survivors. Responses were calculated using descriptive statistics and compared based on the distance participants traveled to their appointments at the cancer center (≤30 vs. >30 miles). Of the 150 respondents, 35% traveled >30 miles for follow-up care and 78% reported having one or more comorbid condition(s). PC utilization was high: 88% reported having a PCP, and 91% indicated ≤1 yearly follow-up visit. Participants traveling >30 miles reported higher rates of logistical challenges associated with cancer center visits compared to those traveling ≤30 miles. Nearly half of respondents (46%) had not received SCD. In conclusion, survey studies such as these allow for the systematic assessment of survivor behaviors and care utilization patterns to inform the development of care coordination interventions for diverse, low-risk cancer patients.
ISSN:2072-6694
2072-6694
DOI:10.3390/cancers13174428